Episode

Europe Faces Climate Onslaught, FDA Boosts Infant Formula Safety, ELREXFIO Shows Promise in Myeloma, AI Tool Redefines Obesity Risk, and more...

Podcast
Science News Daily
Published
Apr 30, 2026
Duration seconds
710
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/0ca4f622
Audio
https://media.transistor.fm/0ca4f622/95eb2efe.mp3
JSON
/v1/public/podcasts/science-news-daily-6698943/episodes/europe-faces-climate-onslaught-fda-boosts-infant-formula-safety-elrexfio-shows-promise-in-myeloma-ai-tool-redefines-obesity-risk-and-more
Markdown
/podcast/science-news-daily-6698943/europe-faces-climate-onslaught-fda-boosts-infant-formula-safety-elrexfio-shows-promise-in-myeloma-ai-tool-redefines-obesity-risk-and-more.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/science-news-daily-6698943/episodes/europe-faces-climate-onslaught-fda-boosts-infant-formula-safety-elrexfio-shows-promise-in-myeloma-ai-tool-redefines-obesity-risk-and-more/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/science-news-daily-6698943/europe-faces-climate-onslaught-fda-boosts-infant-formula-safety-elrexfio-shows-promise-in-myeloma-ai-tool-redefines-obesity-risk-and-more.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

(0:10): Europe's 2025 Climate Extremes Demand Urgent Action: Heatwaves, Water Crisis, and Energy Challenges (2:15): FDA Enhances Infant Formula Safety with New Testing and Transparency Measures (4:24): Pfizer's ELREXFIO Shows Promising Results in Phase 3 Trial for Relapsed Multiple Myeloma (7:07): New AI Tool Obscore Revolutionizes Obesity Risk Detection, Prioritizes Early Intervention Over BMI Reliance (9:14): Ariane 6 Set to Launch 32 Amazon Leo Satellites on Ambitious VA268 Mission To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: logo